Sign up to save your podcasts
Or
Share TMO EPM / Hemato H9J
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TMO EPM / Hemato H9J
By TMO EPM / Hemato H9J
Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA... more
FAQs about TMO EPM / Hemato H9J:
How many episodes does TMO EPM / Hemato H9J have?
The podcast currently has 72 episodes available.
TMO EPM / Hemato H9J episodes:
May 20, 202672 - Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma 
May 04, 202671 - Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial April 08, 202670 - Intermediate-Dose Cytarabine as Postinduction AML Therapy March 11, 202669 - Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials January 11, 202668 - Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia January 07, 202667 - Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma December 30, 202566 - Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study November 05, 202565 - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma November 02, 202564 - Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin September 01, 202563 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
FAQs about TMO EPM / Hemato H9J:
How many episodes does TMO EPM / Hemato H9J have?
The podcast currently has 72 episodes available.